Krognes Steve E.

EDGAR CIK 0001666236

Denali Therapeutics Inc. - DNLI

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Director
Direct Buys
0
$0
0 Shares
Direct Sells
6
($2.27) M
-95,754 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
01/07/2025
01/08/2025
Sell
-3,339 @ $20.81
 ($69,485) 25,757 (-11.48%) Direct
12/31/2024
10b5-1
01/03/2025
Sell
-30,000 @ $20.25
 ($607,500) 29,096 (-50.76%) Direct
09/30/2024
10b5-1
10/02/2024
Sell
-30,000 @ $29.03
 ($870,900) 29,096 (-50.76%) Direct
08/20/2024
08/22/2024
Sell
-1,727 @ $23.79
 ($41,085) 32,677 (-5.02%) Direct
07/01/2024
10b5-1
07/03/2024
Sell
-30,000 @ $22.12
 ($663,668) 34,404 (-46.58%) Direct
06/13/2024
07/03/2024
Sell
-688 @ $21.79
 ($14,992) 52,620 (-1.29%) Direct